NEW OPHTHALMIC USES FOR EXISTING DRUGS

Chairpersons:

Dr. Peter Kador, Univ. Nebraska Medical Center

Dr. Illés Kovács, Semmelweis University, Hungary

 

Confirmed speakers include:

Dr. Marjorie Lou, Univ. Nebraska at Lincoln

THIOREDOXIN ACTIVITY AND TBP2 EXPRESSION IN DIABETIC LENSES ARE LINKED TO ALDOSE REDUCTASE ACTIVITY

Dr. Milton Wyman, Therapeutic Vision, Inc

TOPICAL ALDOSE REDUCTASE INHIBITOR KINOSTAT PREVENTS THE CLINICAL DEVELOPMENT OF CATARACT IN DIABETIC DOGS – AN UPDATE

Dr. Peter Kador, Univ. Nebraska Medical Center

TRANSGENIC AK-SMAA-GFPHAR MICE SUPPORT THE PREMISE THAT ALDOSE REDUCTASE INITIATES DIABETIC RETINOPATHY

14 December 2012